Bradford Dickerson is a Neurology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 577 publications with 44,755 citations (h-index 87). By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
15 Parkman St
Wacc 835
Boston, MA 021143117
Telephone
617-726-1728Registry record last updated 6 Nov 2012.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year20253 payments
- Novo Nordisk IncProgram year20251 payment
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Cholinesterase Inhibitor38.6%Donepezil Hcl86%Galantamine Er14%Part D<11 patientsSSRI32%Citalopram Hbr33%Sertraline Hcl27%Trazodone Hcl22%Escitalopram Oxalate18%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
35 NIH research awards on record, funded 2003–2026 per NIH RePORTER. The latest:
- Robust detection of atrophy over short intervals in AD and FTLD
Massachusetts General Hospital
FY2026$834,693R01AG081249 - Influence of the Menopausal Transition and Lifetime Ovarian Exposure on Neural Metabolism, Connectivity and Pathology
Massachusetts General Hospital
FY2026$825,324R01AG085643 - Toward Personalized Prognosis and Outcomes in Primary Progressive Aphasia
Massachusetts General Hospital
FY2026$823,683R01NS131395
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”